Statin therapy increased risk for 4 of 66 adverse outcomes listed in product labels compared with placebo at a median 4.5 y

Key Points

• To evaluate the risk of adverse outcomes associated with statin therapy compared to placebo.
• Compared 66 adverse outcomes listed in product labels between statin therapy and placebo.
• Conducted a randomized trial with a median follow-up of 4.5 years.
• Statin therapy increased risk for 4 of the 66 adverse outcomes compared to placebo.